These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The influence of ethnicity and antidepressant pharmacogenetics in the treatment of depression. Jann MW; Cohen LJ Drug Metabol Drug Interact; 2000; 16(1):39-67. PubMed ID: 10820582 [TBL] [Abstract][Full Text] [Related]
4. Antidepressant drug selection: criteria and options. Preskorn SH J Clin Psychiatry; 1994 Sep; 55 Suppl A():6-22; discussion 23-4, 98-100. PubMed ID: 7961544 [TBL] [Abstract][Full Text] [Related]
5. Antidepressant pharmacodynamics, pharmacokinetics, and drug interactions. Ereshefsky L Geriatrics; 1998 Dec; 53 Suppl 4():S22-33. PubMed ID: 9861902 [No Abstract] [Full Text] [Related]
6. [Pharmacotherapy of depression in primary care--an update]. Holsboer-Trachsler E Ther Umsch; 2009 Jun; 66(6):407-11. PubMed ID: 19496036 [TBL] [Abstract][Full Text] [Related]
8. [Rational use of antidepressants in general medicine]. Verbanck P; Cnockaert P Rev Med Brux; 1996 Sep; 17(4):224-9. PubMed ID: 8927850 [TBL] [Abstract][Full Text] [Related]
11. Early onset of antidepressant action: impact on primary care. Culpepper L J Clin Psychiatry; 2001; 62 Suppl 4():4-6; discussion 37-40. PubMed ID: 11229788 [TBL] [Abstract][Full Text] [Related]
12. Compliance with antidepressants in a primary care setting, 2: the influence of gender and type of impairment. Demyttenaere K; Enzlin P; Dewé W; Boulanger B; De Bie J; De Troyer W; Mesters P J Clin Psychiatry; 2001; 62 Suppl 22():34-7. PubMed ID: 11599646 [TBL] [Abstract][Full Text] [Related]
13. New approaches to antidepressant drug discovery: beyond monoamines. Berton O; Nestler EJ Nat Rev Neurosci; 2006 Feb; 7(2):137-51. PubMed ID: 16429123 [TBL] [Abstract][Full Text] [Related]
14. Use of antidepressant medications in the general practice setting. A critical review. Hegarty K; Ames D; Anderson J; Johnson C; McKinnon R; Moulds R Aust Fam Physician; 2003 Apr; 32(4):229-34, 236-7, 239 passim. PubMed ID: 12735262 [TBL] [Abstract][Full Text] [Related]
15. Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness. Dechant KL; Clissold SP Drugs; 1991 Feb; 41(2):225-53. PubMed ID: 1709852 [TBL] [Abstract][Full Text] [Related]
16. Antidepressants and drug-metabolizing enzymes--expert group report. Meyer UA; Amrein R; Balant LP; Bertilsson L; Eichelbaum M; Guentert TW; Henauer S; Jackson P; Laux G; Mikkelsen H; Peck C; Pollock BG; Priest R; Sjöqvist F; Delini-Stula A Acta Psychiatr Scand; 1996 Feb; 93(2):71-9. PubMed ID: 8686486 [TBL] [Abstract][Full Text] [Related]
18. Treating depression in the elderly: an update on antidepressants. Buffum MD; Buffum JC Geriatr Nurs; 2005; 26(3):138-42. PubMed ID: 15973338 [No Abstract] [Full Text] [Related]
19. Can long-term treatment with antidepressant drugs worsen the course of depression? Fava GA J Clin Psychiatry; 2003 Feb; 64(2):123-33. PubMed ID: 12633120 [TBL] [Abstract][Full Text] [Related]
20. [Current concepts on the subject of properties and use of antidepressants]. Białecka M Pol Merkur Lekarski; 1997 Apr; 2(10):295-7. PubMed ID: 9377672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]